Study Identifies Gene Variations for Mouth Ulcers
By LabMedica International staff writers Posted on 18 Mar 2019 |
Image: A mouth ulcer (in this case associated with aphthous stomatitis) on the labial mucosa (lining of the lower lip) (Photo courtesy of Wikimedia Commons).
An extensive genome-wide association study (GWAS) identified 97 common genetic variations that predisposed people to suffer from mouth ulcers.
Mouth ulcers are the most common ulcerative condition and encompass several clinical diagnoses, including recurrent aphthous stomatitis (RAS). Despite previous evidence for heritability, it is not clear which specific genetic loci are implicated in RAS.
To identify gene loci linked to development of mouth ulcers, investigators at the University of Bristol (United Kingdom) analyzed genetic data derived from over 450,000 participants in the U.K. Biobank and replicated these findings in over 350,000 participants in the U.S.-based data collection 23andMe.
Results obtained by this genome-wide association study estimated heritability at 8.2%. The study found 97 variants that altered the odds of developing non-specific mouth ulcers. Additional effect estimates from three independent cohorts with more specific phenotyping and specific study characteristics supported many of these findings. Computer-based functional analyses provided evidence for a role of T-cell regulation in the etiology of mouth ulcers.
"Currently, there are few satisfactory drug treatments for mouth ulcers as current medication options are non specific and can lead to side effects. The field has gone from very little genetic understanding of mouth ulcers to having up to 97 areas of the genome, which may provide an excellent basis for future research," said first author Tom Dudding, a graduate student researcher at the University of Bristol. "Importantly, our findings also show that several of the genes related to mouth ulcers are in pathways which are already targeted by drugs that are used to treat other diseases such as rheumatoid arthritis and psoriasis. There is the potential that drugs like these could be used to treat mouth ulcers, although further work is required to demonstrate this."
Details of the study were published in the March 5, 2019, online edition of the journal Nature Communications.
Related Links:
University of Bristol
Mouth ulcers are the most common ulcerative condition and encompass several clinical diagnoses, including recurrent aphthous stomatitis (RAS). Despite previous evidence for heritability, it is not clear which specific genetic loci are implicated in RAS.
To identify gene loci linked to development of mouth ulcers, investigators at the University of Bristol (United Kingdom) analyzed genetic data derived from over 450,000 participants in the U.K. Biobank and replicated these findings in over 350,000 participants in the U.S.-based data collection 23andMe.
Results obtained by this genome-wide association study estimated heritability at 8.2%. The study found 97 variants that altered the odds of developing non-specific mouth ulcers. Additional effect estimates from three independent cohorts with more specific phenotyping and specific study characteristics supported many of these findings. Computer-based functional analyses provided evidence for a role of T-cell regulation in the etiology of mouth ulcers.
"Currently, there are few satisfactory drug treatments for mouth ulcers as current medication options are non specific and can lead to side effects. The field has gone from very little genetic understanding of mouth ulcers to having up to 97 areas of the genome, which may provide an excellent basis for future research," said first author Tom Dudding, a graduate student researcher at the University of Bristol. "Importantly, our findings also show that several of the genes related to mouth ulcers are in pathways which are already targeted by drugs that are used to treat other diseases such as rheumatoid arthritis and psoriasis. There is the potential that drugs like these could be used to treat mouth ulcers, although further work is required to demonstrate this."
Details of the study were published in the March 5, 2019, online edition of the journal Nature Communications.
Related Links:
University of Bristol
Latest Molecular Diagnostics News
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer
- Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer
- Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer
- Simple PCR Assay Accurately Differentiates Between Small Cell Lung Cancer Subtypes
- Revolutionary T-Cell Analysis Approach Enables Cancer Early Detection
- Single Genetic Test to Accelerate Diagnoses for Rare Developmental Disorders
- Upgraded Syndromic Testing Analyzer Enables Remote Test Results Access
- Respiratory and Throat Infection PCR Test Detects Multiple Pathogens with Overlapping Symptoms
- Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis
- First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety
- Fluid Biomarker Test Detects Neurodegenerative Diseases Before Symptoms Appear